Transitional Cell Carcinoma and Pseudocirrhosis— A Case Report and Review of the Literature

Gilad Borisovsky; Daniel A. Goldstein; Noa Eliakim-Raz; Shlomit R. Tamir

doi:10.1055/s-0040-1713829

Journal of Gastrointestinal and Abdominal Radiology, Table of Contents

CC BY-NC-ND 4.0 · Journal of Gastrointestinal and Abdominal Radiology 2020; 3(S 01): S73-S76
DOI: 10.1055/s-0040-1713829

Case Report

Transitional Cell Carcinoma and Pseudocirrhosis— A Case Report and Review of the Literature

Gilad Borisovsky

¹Radiology Department, Rabin Medical Center, Petah Tikva, Israel, affliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

,

Daniel A. Goldstein

²Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel, affliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

,

Noa Eliakim-Raz

³Internal Medicine E, Rabin Medical Center, Petah Tikva, Israel, affliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

,

Shlomit R. Tamir

¹Radiology Department, Rabin Medical Center, Petah Tikva, Israel, affliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

› Author Affiliations

Abstract

Pseudocirrhosis is the occurrence of capsular retraction in patients with metastatic liver disease, usually of breast origin. It usually appears in these patients following chemotherapy and may result from shrinkage of the tumor, with scarring and nodular regeneration. In this article, we describe the first case of pseudocirrhosis, following treatment of transitional cell carcinoma metastatic to the liver. Portal vein thrombosis, a rare complication in pseudocirrhosis, was also detected in this patient.

Keywords

pseudocirrhosis - liver - metastasis - transitional cell carcinoma - chemotherapy - complications - portal vein thrombosis.

Full Text

References

References
1 Jeong WK, Choi SY, Kim J. Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer. Clin Mol Hepatol 2013; 19 (02) 190-194
2 Lipson JA, Qayyum A, Avrin DE, Westphalen A, Yeh BM, Coakley FVCT. CT and MRI of hepatic contour abnormalities. AJR Am J Roentgenol 2005; 184 (01) 75-81
3 Jha P, Poder L, Wang ZJ, Westphalen AC, Yeh BM, Coakley FV. Radiologic mimics of cirrhosis. AJR Am J Roentgenol 2010; 194 (04) 993-999
4 Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 1994; 163 (06) 1385-1388
5 Fennessy FM, Mortele KJ, Kluckert T. et al. Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis. AJR Am J Roentgenol 2004; 182 (03) 651-655
6 Qayyum A, Lee GK, Yeh BM, Allen JN, Venook AP, Coakley FV. Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver. Clin Imaging 2007; 31 (01) 6-10
7 Kang SP, Taddei T, McLennan B, Lacy J. Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management. World J Gastroenterol 2008; 14 (10) 1622-1624
8 Mitani S, Kadowki T, Taniquchi H, Muto H, Muro K.. Pseudocirrhosis in gastric cancer with diffuse liver metastases after a dramatic response to chemotherapy. Case Rep Oncol 2016; 9 (01) 106-111
9 Kobashigawa C, Nakamoto M, Hokama A, Hirata T, Kinjo F, Fujita J. Pseudocirrhosis in metastatic esophageal cancer. South Med J 2010; 103 (05) 488-489
10 Battisti S, Guida FM, Pagliara E, Tonini G, Zobel BB, Santini D. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view. Clin Colorectal Cancer 2014; 13 (03) e13-e15
11 Ojeda VJ. Metastatic oat cell carcinoma simulating liver cirrhosis. N Z Med J 1977; 86 (600) 480-481
12 Harry BL, Smith ML, Burton JR, Dasari A, Eckhardt SG, Diamond JR. Medullary thyroid cancer and pseudocirrhosis: case report and literature review. Curr Oncol 2012; 19 (01) e36-e41
13 Cohen J, Hariton E, Kothari D, Pihan GA, Robson SC. Hepatosplenic alpha/beta T-cell lymphoma masquerading as cirrhosis. J Gastrointest Oncol 2013; 4 (02) 131-136
14 Amitrano L, Guardascione MA, Brancaccio V. et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40 (05) 736-741
15 Wu M, Schuster M, Tadros M. Update on management of portal vein thrombosis and the role of novel anticoagulatns. J Clin Transl Hepatol 2019; 7 (02) 154-164
16 Jüngst C, Krämer J, Schneider G, Lammert F, Zimmer V. Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration. Ann Hepatol 2013; 12 (05) 834-836
17 Lubner MG, Pickhardt PJ. Multidetector computed tomography for assessment of hepatic fibrosis. Clin Liver Dis (Hoboken) 2018; 11 (06) 156-161
18 Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44 (01) 7-14
19 Sharma A, Houshyar R, Bhosale P, Choi JI, Gulati R, Lall C. Chemotherapy induced liver abnormalities: an imaging perspective. Clin Mol Hepatol 2014; 20 (03) 317-326